Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Orticumab Biosimilar – Anti-oxLDL mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, lambda |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Orticumab Biosimilar - Anti-oxLDL mAb - Research Grade |
|---|---|
| Source | CAS 1314241-10-5 |
| Species | Homo sapiens |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Orticumab,BI-204,MLDL-1278A,R-7418,oxLDL,anti-oxLDL |
| Reference | PX-TA1299 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-lambda |
| Clonality | Monoclonal Antibody |
Description of Orticumab Biosimilar - Anti-oxLDL mAb - Research Grade
General information on Anti-oxLDL[Homo sapiens] (Orticumab) Monoclonal Antibody
Orticumab is investigated for the treatment of Psoriasis and Cardiometabolic Risk Factors.
Related products
Antigen
Human OLR1 recombinant protein
PX-P6045 392$
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.